GPX4 and cancer: Although our research has uncovered a negative correlation between TNFSF11 and GPX4 at the protein level, and proposed the use of ferroptosis inhibitors for the treatment of TNFSF11 overexpressing cancers, the detailed regulatory mechanisms between TNFSF11 and GPX4 remain unclear and warrants further investigation.